-
541
MicroRNAs as Haematopoiesis Regulators
Published 2013-01-01“…Aberrant expression of miRNAs was observed in hematological malignancies including chronic myelogenous leukemia, chronic lymphocytic leukemia, multiple myelomas, and B cell lymphomas. In this review we have focused on discussing the role of miRNA in haematopoiesis.…”
Get full text
Article -
542
Primary Hepatic Lymphoma: A Challenging Diagnosis
Published 2014-01-01“…After CT-guided biopsy, primary diffuse large B-cells non-Hodgkin lymphoma was revealed. Appropriate chemotherapy improved patient’s condition markedly. …”
Get full text
Article -
543
The Role of Protein Modifications of T-Bet in Cytokine Production and Differentiation of T Helper Cells
Published 2014-01-01“…Numerous studies have demonstrated that T-bet plays multiple roles in many subtypes of immune cells, including B cell, dendritic cells, natural killer (NK) cells, NK T cells, and innate lymphoid cells. …”
Get full text
Article -
544
Systemic lupus erythematosus in a patient with 22q11.2 deletion syndrome: A case report and review of the literature
Published 2024-11-01“…Thymic dysplasia, T-cell lymphopenia, and B-cell abnormalities collectively contribute to the immunodeficiency and autoimmune manifestations observed in individuals with 22q11.2DS. …”
Get full text
Article -
545
A Novel del(20q) in Aggressive Nodal Marginal Zone Lymphoma
Published 2013-01-01“…This was an unexpected finding, as del(20q) is associated with myelodysplastic syndromes and myeloproliferative neoplasms and rarely seen in diffuse large B-cell lymphoma, follicular lymphoma, and T-cell lymphoma, but has not previously been described in MZL. …”
Get full text
Article -
546
Oral plasmablastic lymphoma: at the origin of the discovery of an HIV infection
Published 2024-01-01“…Introduction: Plasmablastic lymphoma is a rare and aggressive malignancy derived from a B cell lineage. It has a predilection for extranodal sites, particularly arises de novo in the oral cavity. …”
Get full text
Article -
547
Breast lymphomas: Clinical and pathological insights from a tertiary cancer care center in India
Published 2024-12-01“…It was seen predominantly in females (82%) and the age range was 31 to 73 years. Diffuse large B cell lymphoma (DLBCL) was the predominant morphology (73%), along with single rare cases of ALK-negative anaplastic large cell lymphoma, Burkitt lymphoma, and small lymphocytic lymphoma. …”
Get full text
Article -
548
Autoimmune Gastrointestinal Paralysis: Failure of Conventional Treatment without Immunomodulation
Published 2014-01-01“…Patients with neuroendocrine-derived tumors can develop B-cell reactivity towards the tumor with cross-reactivity for neurons located in the submucosal and myenteric ganglia of the ENS. …”
Get full text
Article -
549
Bio-mimetic strategies to re-activate apoptotic cell death for cancer treatments
Published 2024-11-01“…The internal (or mitochondrial) and external (or death receptor) pathways are responsible for driving a series of molecular events that lead to apoptosis by releasing pro-apoptotic proteins, such as B-cell lymphoma-2 (BCL-2) homology 3 (BH3)-only proteins and second mitochondria-derived activator of caspases/diablo inhibitor of apoptosis protein-binding mitochondrial protein (SMAC/DIABLO), that in turn activate the caspase family of proteases. …”
Get full text
Article -
550
Characteristics of Suppressor Macrophages Induced by Mycobacterial and Protozoal Infections in relation to Alternatively Activated M2 Macrophages
Published 2012-01-01“…During the course of Mycobacterium tuberculosis (MTB) and Mycobacterium avium-intracellulare complex (MAC) infections, the generation of macrophages which possess strong suppressor activity against host T- and B-cell functions is frequently encountered. This paper describes the immunological properties of M1- and M2-type macrophages generated in tumor-bearing animals and those generated in hosts with certain microbial infections. …”
Get full text
Article -
551
Tirosin Kinase Inhibitors in Chronic Graft versus Host Disease: From Bench to Bedside
Published 2011-01-01“…Moreover accumulating in vitro data confirm that TKIs, interacting with the TCR and other signalling molecules, carry potent immunomodulatory effects, being involved in both T-cell and B-cell response. Translation to the clinical setting revealed that treatment with Imatinib can achieve encouraging responses in patients with autoimmune diseases and steroid-refractory cGVHD, showing a favourable toxicity profile. …”
Get full text
Article -
552
CEACAM5 exacerbates asthma by inducing ferroptosis and autophagy in airway epithelial cells through the JAK/STAT6-dependent pathway
Published 2025-12-01“…CEACAM5 expression was elevated in asthmatic mouse lung tissues and IL-13-stimulated Beas-2B cells, primarily in bronchial epithelial cells. …”
Get full text
Article -
553
Acute Left Internal Carotid Artery and Right Popliteal Artery Occlusion Related to Cisplatin-Gemcitabine Based Chemotherapy
Published 2018-01-01“…We report a case of a 64-year-old male with Diffuse Large B-Cell Non-Hodgkin’s Lymphoma who presented with left-sided headache and right calf pain two weeks after starting Rituximab/Gemcitabine/Cisplatin/Dexamethasone chemotherapy. …”
Get full text
Article -
554
Successful Treatment of Severe Type B Lactic Acidosis in a Patient with HIV/AIDS-Associated High-Grade NHL
Published 2018-01-01“…Biopsy of the abdominal mass demonstrated a high-grade diffuse large B-cell lymphoma. The patient’s lactic acidosis resolved after starting chemotherapy, and a complete response was evident on PET-CT after a third cycle of rituximab, etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (EPOC-RR). …”
Get full text
Article -
555
Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy
Published 2016-01-01“…Innate immune cells are crucial in the initial onset of disease and their response is followed by adaptive T (Th1, Th17, and cytotoxic T cells) and B cell responses evidenced by liver histology and peripheral blood serology. …”
Get full text
Article -
556
Survival Analysis by Penalized Regression and Matrix Factorization
Published 2013-01-01“…We tried L1- (lasso), L2- (ridge), and L1-L2 combined (elastic net) penalized regression for diffuse large B-cell lymphoma (DLBCL) patients' microarray data and found that L1-L2 combined method predicts survival best with the smallest logrank P value. …”
Get full text
Article -
557
Large-scale manufacturing and characterization of CMV-CD19CAR T cells
Published 2022-01-01“…Background Adoptive transfer of CD19-specific chimeric antigen receptor (CD19CAR) T cells can induce dramatic disease regression in patients with B cell malignancies. CD19CAR T cell therapy may be limited by insufficient engraftment and persistence, resulting in tumor relapse. …”
Get full text
Article -
558
SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report
Published 2023-01-01“…Patients undergoing chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory B-cell malignancies are uniquely immunosuppressed due to CAR T-mediated B-cell aplasia (BCA). …”
Get full text
Article -
559
Apelin Protects Primary Rat Retinal Pericytes from Chemical Hypoxia-Induced Apoptosis
Published 2015-01-01“…Furthermore, exogenous recombinant apelin effectively prevented hypoxia-induced apoptosis through downregulating active-caspase 3 expression and increasing the ratio of B cell lymphoma-2 (Bcl-2)/Bcl-2 associated X protein (Bax) in pericytes. …”
Get full text
Article -
560
Primary Hairy Cell Leukemia/Lymphoma of the Breast: A Case Report and Review of the Literature
Published 2014-01-01“…Hairy cell leukemia/lymphoma (HCL) is a rare B-cell neoplasm primarily involving spleen, bone marrow, and blood. …”
Get full text
Article